DoW Alzheimer’s Transforming Research Award

Defense Health Agency Contracting Activity - DHACAAmount not specifiedDue Sep 24, 2026

Researchers Schools & universities Nonprofits Small business Broad eligibility

Deadline: Sep 24, 2026
Posted: May 1, 2026
Award amount: Amount not specified
Focus areas: Science and Technology and other Research and Development

Don’t miss this deadline

We’ll email you before Sep 24, 2026 so you have time to apply.

In plain English

This Department of Defense (CDMRP) Alzheimer's Research Program Transforming Research Award funds non-incremental research on reducing risk and preventing Alzheimer's disease and related dementias, focused on risk factor knowledge or risk reduction solutions. Eligibility is described as unrestricted (open to any eligible entity type), subject to clarifications in the announcement. Clinical research is allowed but clinical trials and animal research are prohibited, preliminary data are required, and community collaboration is required when prospectively enrolling human subjects. No specific award amount is stated.

AI-generated summary to help you decide quickly — verify the official eligibility rules before applying.

Who can apply

Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

About this grant

Summary: The fiscal year 2026 (FY26) Alzheimer’s Research Program (AZRP) Transforming Research Award (TrRA) supports non-incremental, robust, well-designed research that drives transformative advancements in reducing risk and preventing the development of Alzheimer’s disease and/or Alzheimer's disease related dementias (AD/ADRD). Distinctive Features: • Applications must address at least one of the following focus areas: ○ Risk Factor Knowledge: Research that advances understanding, identification, and/or validation of risk and/or protective factors, with research outcomes/products focused on accelerating solutions. Projects may include, but are not limited to, research on environmental, epigenetic, genetic, lifestyle, occupational, or other risks not listed here. ○ Risk Reduction Solutions: Research that describes methods, technologies, and strategies that contribute to reducing risk and preventing AD/ADRD. • Clinical research is allowed, however clinical trials and animal research are prohibited. • Preliminary data are required. • Community collaboration is required for research prospectively enrolling human subjects. • Career Initiation or Transition (CIT) Partnership Option: The TrRA includes an option for more than one PI and supports both new and existing collaborative partnerships. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). If utilizing this option, at least one independent investigator must meet

Let AI draft your application

Your first draft is free: a narrative and budget outline tailored to this grant, emailed to you. Drafts are written in a nightly batch, so it arrives by email later — not instantly on this page.

Application Kit — $49 one-time

Winner intelligence + a first-draft narrative grounded in applications that actually won. One payment, no subscription.

Get the Application Kit →

Related grants

Other open grants funding Science and Technology and other Research and Development — soonest deadline first.

Also listed under Defense Health Agency Contracting Activity - DHACA and Science & Research Grants.

Source: public records via Grants.gov. UseGrants is an independent aggregator, not affiliated with any funding agency. Always confirm details on the official listing before applying.

DoW Alzheimer&rsquo;s Transforming Research Award